分泌IgA是肠道屏障功能障碍相关免疫球蛋白中的关键标记物,可预测ACLF的结果
Boglarka Balogh1,2, David Tornai1, Aniko Csillag1
1Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
概括
在肝硬化症中,高分泌IgA (sIgA) 表示肠道屏障衰竭,并预测急性-慢性肝衰竭 (ACLF) 患者的90天死亡风险更高. 这一发现为ACLF患者提供了一个新的预后标志物.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 肝硬化中肠道免疫力受损允许细菌转移,恶化肝损伤.
- 抗体介导免疫在肝硬化进展中的作用尚未完全理解.
研究的目的:
- 研究血清免疫球蛋白 (Ig) 作为急性失补偿 (AD) 肝硬化中肠道屏障功能的预后标志物.
- 评估IgA和IgG抗体对肝硬化患者死亡率的预测价值.
主要方法:
- 从128名AD肝硬化患者的血清样本中分析了各种IgA,IgG,IgM和轻链水平.
- 测量了针对肠道相关点的特定抗体.
- 死亡率被追踪了90天,在一个独立的ACLF队列中进行了验证.
主要成果:
- 总IgA和标特定IgA抗体的升高与疾病严重程度相关.
- 在ACLF患者中,分泌IgA (sIgA) 水平随着ACLF严重程度的增加而增加,预计90天死亡率 (AUROC: 0.859).
- 在合并的ACLF队列中,高sIgA独立预测了90天的死亡率 (HR:3.367).
结论:
- 增加的IgA抗体表明在肝硬化中增强了细菌转位触发的免疫激活.
- 血清sIgA是肠道屏障功能障碍的有希望的生物标志物,并预测ACLF的90天死亡率.
相关概念视频
Transcytosis of IgG
4.1K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
4.1K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
644
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
644
Chronic Bowel Disorders: Introduction
747
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
747
Irritable Bowel Syndrome I: Introduction
924
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
924
Inflammatory Bowel Disease I: Ulcerative Colitis
903
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
903
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
732
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
732


